Processa Pharmaceuticals, Inc.

NasdaqCM:PCSA Stock Report

Market Cap: US$2.0m

Processa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PCSA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Jan 25BuyUS$34,691Patrick LinIndividual43,500US$0.80
27 Jan 25BuyUS$69,542George NgIndividual87,200US$0.80
27 Jan 25BuyUS$99,289David YoungIndividual124,500US$0.80
27 Jan 25BuyUS$9,889Justin YorkeIndividual12,400US$0.80

Insider Trading Volume

Insider Buying: PCSA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PCSA?
Owner TypeNumber of SharesOwnership Percentage
Public Companies62,5001.32%
Institutions98,9352.09%
Private Companies118,6842.51%
Individual Insiders457,3059.65%
General Public3,999,86484.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 177.4%.

Top Shareholders

Top 22 shareholders own 15.57% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
4.56%
David Young
216,191US$91.9k136%no data
2.26%
George Ng
107,200US$45.6k436%no data
1.53%
Patrick Lin
72,559US$30.8k150%no data
1.32%
Yuhan Corporation
62,500US$26.6k0%no data
1.19%
CorLyst, LLC
56,467US$24.0k0%no data
0.67%
Hudson River Trading LLC, Asset Management Arm
31,971US$13.6k0%no data
0.66%
Richland Fund LLC
31,232US$13.3k0%no data
0.65%
Young Plaisance Revocable Trust
30,985US$13.2k0%no data
0.52%
The Vanguard Group, Inc.
24,433US$10.4k0%no data
0.46%
Geode Capital Management, LLC
21,982US$9.3k11.6%no data
0.46%
Sian Bigora
21,878US$9.3k0%no data
0.34%
Justin Yorke
16,137US$6.9k332%no data
0.25%
Wendy Guy
11,857US$5.0k0%no data
0.21%
Composition Wealth, LLC
10,000US$4.3k0%no data
0.17%
UBS Asset Management AG
7,908US$3.4k1,420%no data
0.14%
James Stanker
6,482US$2.8k0%no data
0.061%
Geraldine Pannu
2,882US$1.2k0%no data
0.052%
Tower Research Capital Europe Limited
2,462US$1.0k-32.4%no data
0.03%
Khoso Baluch
1,398US$594.10%no data
0.015%
James Neal
721US$306.40%no data
0.0032%
Wells Fargo & Company, Securities and Brokerage Investments
154US$65.40%no data
0.00053%
Bank of America Corporation, Asset Management Arm
25US$10.74.17%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/19 11:56
End of Day Share Price 2025/03/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Processa Pharmaceuticals, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robin Garner KalleyCraig-Hallum Capital Group LLC
Raghuram SelvarajuH.C. Wainwright & Co.
François BriseboisOppenheimer & Co. Inc.